SIC 8071 – Medical Laboratories
| Valuation | |
|---|---|
| Market Cap ($M) | 488.77 |
| Enterprise Value ($M) | 495.15 |
| Book Value ($M) | 139.77 |
| Book Value / Share | 4.59 |
| Price / Book | 3.50 |
| NCAV ($M) | 139.14 |
| NCAV / Share | 4.57 |
| Price / NCAV | 3.51 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.36 |
| Return on Assets (ROA) | -0.39 |
| Return on Equity (ROE) | -0.52 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 13.43 |
| Current Ratio | 13.43 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 190.59 |
| Assets | 191.22 |
| Liabilities | 51.45 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -66.23 |
| Net Income | -63.78 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -53.81 |
| Cash from Investing | -5.01 |
| Cash from Financing | 64.91 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Ra Capital Management, L.p. | 5.00 | -42.79 | |
| 13G/A | Venrock Healthcare Capital Partners III, L.P. | 9.99 | ||
| 13G/A | Commodore Capital Lp | 9.90 | 10.43 | |
| 13G/A | Perceptive Advisors Llc | 6.10 | 2.78 | |
| 13G/A | Morgan Stanley | 9.10 | 101.04 | |
| 13G/A | Soleus Capital Master Fund, L.P. | 9.90 | 14.80 | |
| 13G/A | Laing Lance G. | 5.50 | 3.44 | |
| 13G/A | Sullivan Brian F. | 14.00 | 4.84 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 13,558 | 103,622 | 13.08 | |
| 18,103 | 77,052 | 23.49 | |
| 20,131 | 104,964 | 19.18 | |
| 20,501 | 72,637 | 28.22 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BGLC – BioNexus Gene Lab Corp. | DMTK – DermTech, Inc. |
| EXAS – Exact Sciences Corporation |
Financial data and stock pages provided by
Fintel.io